Brief: Cosmos Health Targets $200 Mln Revenue, $44 Mln Adjusted EBITDA By 2029
26/05/2026 14:39
BRIEF-Cosmos Health Targets $200 Mln Revenue, $44 Mln Adjusted EBITDA By 2029 May 26 (Reuters) - Cosmos Health Inc COSM.O:
COSMOS HEALTH RELEASES 2026–2029 GUIDANCE: TARGETING $200M REVENUE, $71M GROSS PROFIT, AND $44M ADJUSTED EBITDA BY 2029 — BUILDING AN INNOVATIVE, HIGH-MARGIN HEALTHCARE PLATFORM WITH STRONG CASH GENERATION
COSMOS HEALTH- PROJECTS 2029 STOCKHOLDERS' EQUITY OF $92.3 MILLION PER-SHARE VALUE CREATION WITH $0.73 EPS
COSMOS HEALTH INC - EXPECTS PROFITABILITY IN 2027, NET INCOME $31 MILLION BY 2029
Source text: ID:nGNX8Qy556
Further company coverage: COSM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cosmos Health
See all newsCosmos Health Q3 revenue rises to record high on contract manufacturing
Brief: Cosmos Health Secures Additional 2.5 Mln Units Under New Five-Year Contract Manufacturing Deal With Viofar
Brief: Cosmos Health Reaffirms 2029 Guidance
Brief: Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Deal With Innova Healthcare
Brief: Cosmos Health Reports Q2 2026